Posted On: 03/10/2014 7:35:54 AM
Post# of 109
Latest Itonis Inc (ITNS) Headlines
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.
Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products
Marketwire - Mon Dec 09, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce today the addition of Ernesto Barron to Dr. Hensley's product development team. Mr. Barron will serve as Itonis Phamaceuticals' Chief Scientific Officer and Director of Clinical Research.
Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl Brand of Nausea Remedy
Marketwire - Wed Dec 04, 9:58AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has completed packaging graphics for its Emesyl(TM) Nausea Remedy.
Itonis Pharmaceuticals to Conduct Case Study for Its Emesyl Brand of Nausea Remedy
Marketwire - Mon Dec 02, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company will conduct a case study to confirm the efficacy of its Emesyl(TM) Nausea Remedy in a clinical setting.
Itonis Pharmaceuticals and Dr. Charles Hensley to Receive Delivery of First Production Batch of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 25, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are to receive first batch of Emesyl(TM) product, the Company's over-the-counter homeopathic product for the relief of nausea.
Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 18, 8:50AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to release their manufacturing update for Emesyl(TM), the Company's over-the-counter homeopathic product for the relief of nausea.
Itonis Pharmaceuticals to Trademark Emesyl Nausea Relief Remedy
Marketwire - Thu Oct 24, 9:30AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has applied to the USPTO to trademark its Emesyl brand for its homeopathic pharmaceutical nausea relief remedy. The Company's application has been assigned Serial No. 86099093.
Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico
Marketwire - Thu Sep 12, 7:30AM CDT
Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD") will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners.
Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status
Marketwire - Wed Jul 31, 8:02AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Distribute Homeopathic Products in Retail Chains
Marketwire - Fri Jul 19, 8:45AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company's line of homeopathic products will be distributed nationally and internationally by Hensley Brothers Distribution, LLC.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Obtain FDA Labeler Status
Marketwire - Tue Jun 25, 1:30PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce the Company has commenced the application process to file with the U.S. Food and Drug Administration as a labeler.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy, And Itonis Pharmaceuticals Prepared to File for the National Drug Code Number for the Emesyl(tm) Anti-Nausea Products to Launch Sales in Fall 2013
GlobeNewswire - Fri May 31, 8:30AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the Company is prepared to file for the National Drug Code (NDC) number for their over-the-counter Emesyl(TM) homeopathic product.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals to Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 11:53AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 10:00AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy and Itonis Pharmaceuticals to Use Its Exclusive Manufacturer for Emesyl(TM) Anti-Nausea Swab and Oral Spray Products
GlobeNewswire - Fri May 03, 8:55AM CDT
Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company's exclusive manufacturer (Oasis Health Products, Inc.) will produce the Company's anti-nausea swab and its oral spray products under the Emesyl(TM) brand.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy and Itonis Pharmaceuticals Enter Into Exclusive Agreement With Manufacturer for Anti-Nausea Spray Products
GlobeNewswire - Fri May 03, 5:53AM CDT
Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company's manufacturer (Oasis Health Products, Inc.) has agreed to manufacture nasal spray, oral spray and nasal swab delivery form products for the relief and treatment of nausea for Itonis, Inc. exclusively.
Oasis Health Products to Provide Manufacturing Services for Itonis Pharmaceuticals' Anti-Nausea Products
GlobeNewswire - Thu May 02, 3:25PM CDT
Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company has entered into a manufacturing agreement with Oasis Health Products, Inc. to manufacture Emesyl(TM), the company's over-the-counter homeopathic products for the relief of nausea.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals Add Sublingual Spray Application to Anti-Nausea Product
GlobeNewswire - Tue Apr 16, 8:12AM CDT
Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that Itonis Pharmaceuticals plans to offer an oral sublingual spray as a third method of delivery to its recently announced over-the-counter homeopathic nasal spray and nasal swabs for the treatment of nausea.
Active Penny Stock Reports: (OTC Pink: ITNS), (OTCQB: AAMRQ)
ACCESSWIRE-TNW - Sun Mar 31, 4:59PM CDT
New York (March 31st, 2013) - Itonis Inc. (OTC Pink: ITNS) and Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, announced their initial marketing plans for their over-the-counter homeopathic products for the relief of nausea.
Stocks In The News: (OTC Pink: ITNS), (OTCQB: AAMRQ)
ACCESSWIRE-TNW - Thu Mar 28, 12:31PM CDT
New York (March 28th, 2013) - ITonis Inc. (OTC Pink: ITNS) stock is trading at $0.0061, up 14.81 percent from its previous close. The stock is up with the volume of 145.44 million, substantially higher than its usual volume of 668k shares. ITonis stock opened the session at $0.01. The stock is currently in the bullish mode and is likely to continue the trend as shown by its MACD chart. ITonis commands market capitalization of $1.80 million. The stock trades at beta of 1.54 and is volatile.
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.
Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products
Marketwire - Mon Dec 09, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce today the addition of Ernesto Barron to Dr. Hensley's product development team. Mr. Barron will serve as Itonis Phamaceuticals' Chief Scientific Officer and Director of Clinical Research.
Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl Brand of Nausea Remedy
Marketwire - Wed Dec 04, 9:58AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has completed packaging graphics for its Emesyl(TM) Nausea Remedy.
Itonis Pharmaceuticals to Conduct Case Study for Its Emesyl Brand of Nausea Remedy
Marketwire - Mon Dec 02, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company will conduct a case study to confirm the efficacy of its Emesyl(TM) Nausea Remedy in a clinical setting.
Itonis Pharmaceuticals and Dr. Charles Hensley to Receive Delivery of First Production Batch of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 25, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are to receive first batch of Emesyl(TM) product, the Company's over-the-counter homeopathic product for the relief of nausea.
Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 18, 8:50AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to release their manufacturing update for Emesyl(TM), the Company's over-the-counter homeopathic product for the relief of nausea.
Itonis Pharmaceuticals to Trademark Emesyl Nausea Relief Remedy
Marketwire - Thu Oct 24, 9:30AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has applied to the USPTO to trademark its Emesyl brand for its homeopathic pharmaceutical nausea relief remedy. The Company's application has been assigned Serial No. 86099093.
Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico
Marketwire - Thu Sep 12, 7:30AM CDT
Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD") will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners.
Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status
Marketwire - Wed Jul 31, 8:02AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Distribute Homeopathic Products in Retail Chains
Marketwire - Fri Jul 19, 8:45AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company's line of homeopathic products will be distributed nationally and internationally by Hensley Brothers Distribution, LLC.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Obtain FDA Labeler Status
Marketwire - Tue Jun 25, 1:30PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce the Company has commenced the application process to file with the U.S. Food and Drug Administration as a labeler.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy, And Itonis Pharmaceuticals Prepared to File for the National Drug Code Number for the Emesyl(tm) Anti-Nausea Products to Launch Sales in Fall 2013
GlobeNewswire - Fri May 31, 8:30AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the Company is prepared to file for the National Drug Code (NDC) number for their over-the-counter Emesyl(TM) homeopathic product.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals to Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 11:53AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 10:00AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy and Itonis Pharmaceuticals to Use Its Exclusive Manufacturer for Emesyl(TM) Anti-Nausea Swab and Oral Spray Products
GlobeNewswire - Fri May 03, 8:55AM CDT
Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company's exclusive manufacturer (Oasis Health Products, Inc.) will produce the Company's anti-nausea swab and its oral spray products under the Emesyl(TM) brand.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy and Itonis Pharmaceuticals Enter Into Exclusive Agreement With Manufacturer for Anti-Nausea Spray Products
GlobeNewswire - Fri May 03, 5:53AM CDT
Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company's manufacturer (Oasis Health Products, Inc.) has agreed to manufacture nasal spray, oral spray and nasal swab delivery form products for the relief and treatment of nausea for Itonis, Inc. exclusively.
Oasis Health Products to Provide Manufacturing Services for Itonis Pharmaceuticals' Anti-Nausea Products
GlobeNewswire - Thu May 02, 3:25PM CDT
Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company has entered into a manufacturing agreement with Oasis Health Products, Inc. to manufacture Emesyl(TM), the company's over-the-counter homeopathic products for the relief of nausea.
Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals Add Sublingual Spray Application to Anti-Nausea Product
GlobeNewswire - Tue Apr 16, 8:12AM CDT
Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that Itonis Pharmaceuticals plans to offer an oral sublingual spray as a third method of delivery to its recently announced over-the-counter homeopathic nasal spray and nasal swabs for the treatment of nausea.
Active Penny Stock Reports: (OTC Pink: ITNS), (OTCQB: AAMRQ)
ACCESSWIRE-TNW - Sun Mar 31, 4:59PM CDT
New York (March 31st, 2013) - Itonis Inc. (OTC Pink: ITNS) and Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, announced their initial marketing plans for their over-the-counter homeopathic products for the relief of nausea.
Stocks In The News: (OTC Pink: ITNS), (OTCQB: AAMRQ)
ACCESSWIRE-TNW - Thu Mar 28, 12:31PM CDT
New York (March 28th, 2013) - ITonis Inc. (OTC Pink: ITNS) stock is trading at $0.0061, up 14.81 percent from its previous close. The stock is up with the volume of 145.44 million, substantially higher than its usual volume of 668k shares. ITonis stock opened the session at $0.01. The stock is currently in the bullish mode and is likely to continue the trend as shown by its MACD chart. ITonis commands market capitalization of $1.80 million. The stock trades at beta of 1.54 and is volatile.
(0)
(0)
